Found: 84
Select item for more details and to access through your institution.
Quality Indicators for the Diagnosis and Management of Primary Hyperparathyroidism.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Hyperthermic isolated limb perfusion, preoperative radiotherapy, and surgery (PRS) a new limb saving treatment strategy for locally advanced sarcomas.
- Published in:
- Journal of Surgical Oncology, 2018, v. 117, n. 7, p. 1447, doi. 10.1002/jso.25008
- By:
- Publication type:
- Article
PET segmentation of bulky tumors: Strategies and workflows to improve inter-observer variability.
- Published in:
- PLoS ONE, 2020, v. 15, n. 3, p. 1, doi. 10.1371/journal.pone.0230901
- By:
- Publication type:
- Article
Comparison of [<sup>18</sup>F]DOPA and [<sup>68</sup>Ga]DOTA-TOC as a PET imaging tracer before peptide receptor radionuclide therapy.
- Published in:
- European Journal of Hybrid Imaging, 2022, v. 6, n. 1, p. 1, doi. 10.1186/s41824-022-00133-6
- By:
- Publication type:
- Article
Everolimus Induces Rapid Plasma Glucose Normalization in Insulinoma Patients by Effects on Tumor As Well As Normal Tissues.
- Published in:
- Oncologist, 2011, v. 16, n. 6, p. 783, doi. 10.1634/theoncologist.2010-0222
- By:
- Publication type:
- Article
<sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography for Monitoring Response to Sorafenib Treatment in Patients with Hepatocellular Carcinoma.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Shortened duration whole body <sup>18</sup>F-FDG PET Patlak imaging on the Biograph Vision Quadra PET/CT using a population-averaged input function.
- Published in:
- EJNMMI Physics, 2022, v. 9, n. 1, p. 1, doi. 10.1186/s40658-022-00504-9
- By:
- Publication type:
- Article
Convolutional neural networks for automatic image quality control and EARL compliance of PET images.
- Published in:
- EJNMMI Physics, 2022, v. 9, n. 1, p. 1, doi. 10.1186/s40658-022-00468-w
- By:
- Publication type:
- Article
Correlation between Histopathological Prognostic Tumor Characteristics and [ 18 F]FDG Uptake in Corresponding Metastases in Newly Diagnosed Metastatic Breast Cancer.
- Published in:
- Diagnostics (2075-4418), 2024, v. 14, n. 4, p. 416, doi. 10.3390/diagnostics14040416
- By:
- Publication type:
- Article
Additional value of a high sensitive thyroglobulin assay in the follow-up of patients with differentiated thyroid carcinoma.
- Published in:
- Clinical Endocrinology, 2017, v. 86, n. 3, p. 419, doi. 10.1111/cen.13180
- By:
- Publication type:
- Article
Optimization of parathyroid <sup>11</sup>C-choline PET protocol for localization of parathyroid adenomas in patients with primary hyperparathyroidism.
- Published in:
- EJNMMI Research, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1186/s13550-019-0534-5
- By:
- Publication type:
- Article
Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative <sup>18</sup>F-FDG PET/CT analysis.
- Published in:
- EJNMMI Research, 2018, v. 8, n. 1, p. 1, doi. 10.1186/s13550-018-0453-x
- By:
- Publication type:
- Article
Volume of interest delineation techniques for <sup>18</sup>F-FDG PET-CT scans during neoadjuvant extremity soft tissue sarcoma treatment in adults: a feasibility study.
- Published in:
- EJNMMI Research, 2018, v. 8, n. 1, p. 1, doi. 10.1186/s13550-018-0397-1
- By:
- Publication type:
- Article
Improved Localization of Insulinomas Using <sup>68</sup>Ga-NODAGA-Exendin-4 PET/CT.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 12, p. 1959, doi. 10.2967/jnumed.124.268158
- By:
- Publication type:
- Article
Ultrashort Oncologic Whole-Body [<sup>18</sup>F]FDG Patlak Imaging Using LAFOV PET.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 10, p. 1652, doi. 10.2967/jnumed.124.267784
- By:
- Publication type:
- Article
Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative, -Low, and -Positive Metastatic Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 10, p. 1540, doi. 10.2967/jnumed.124.267636
- By:
- Publication type:
- Article
Long Versus Short Axial Field of View Immuno-PET/CT: Semiquantitative Evaluation for <sup>89</sup>Zr-Trastuzumab.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1815, doi. 10.2967/jnumed.123.265621
- By:
- Publication type:
- Article
<sup>89</sup>Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1944, doi. 10.2967/jnumed.121.263470
- By:
- Publication type:
- Article
Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263470
- By:
- Publication type:
- Article
<sup>89</sup>Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263470
- By:
- Publication type:
- Article
<sup>89</sup>Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.263470
- By:
- Publication type:
- Article
<sup>89</sup>Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263470
- By:
- Publication type:
- Article
Assessment of Bone Lesions with 18F-FDG-PET Compared to 99mTechnetium Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.244640
- By:
- Publication type:
- Article
Assessment of Bone Lesions with <sup>18</sup>F-FDG-PET Compared to <sup>99m</sup>Technetium Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.244640
- By:
- Publication type:
- Article
Assessment of Bone Lesions with 18F-FDG-PET Compared to 99mTechnetium Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.244640
- By:
- Publication type:
- Article
Assessment of Bone Lesions with <sup>18</sup>F-FDG-PET Compared to <sup>99m</sup>Technetium Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.120.244640
- By:
- Publication type:
- Article
Long-Term Effects of Radioiodine Treatment on Salivary Gland Function in Adult Survivors of Pediatric Differentiated Thyroid Carcinoma.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 2, p. 172, doi. 10.2967/jnumed.118.212449
- By:
- Publication type:
- Article
Molecular Imaging in Cancer Drug Development.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 5, p. 726, doi. 10.2967/jnumed.116.188045
- By:
- Publication type:
- Article
Theranostics Using Antibodies and Antibody-Related Therapeutics.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, p. 83S, doi. 10.2967/jnumed.116.186940
- By:
- Publication type:
- Article
<sup>89</sup>Zr-Bevacizumab PET: Potential Early Indicator of Everolimus Efficacy in Patients with Metastatic Renal Cell Carcinoma.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 6, p. 905, doi. 10.2967/jnumed.116.183475
- By:
- Publication type:
- Article
Effects of Radioiodine Treatment on Salivary Gland Function in Patients with Differentiated Thyroid Carcinoma: A Prospective Study.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 11, p. 1685, doi. 10.2967/jnumed.115.169888
- By:
- Publication type:
- Article
<sup>89</sup>Zr-Bevacizumab PET Visualizes Disease Manifestations in Patients with von Hippel-Lindau Disease.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 8, p. 1244, doi. 10.2967/jnumed.115.167643
- By:
- Publication type:
- Article
<sup>124</sup>I PET/CT to Predict the Outcome of Blind <sup>131</sup>I Treatment in Patients with Biochemical Recurrence of Differentiated Thyroid Cancer: Results of a Multicenter Diagnostic Cohort Study (THYROPET).
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 5, p. 701, doi. 10.2967/jnumed.115.168138
- By:
- Publication type:
- Article
In Vivo Biodistribution of No-Carrier-Added 6-<sup>18</sup>F-Fluoro-3, 4-Dihydroxy-L-Phenylalanine (<sup>18</sup>F-DOPA), Produced by a New Nucleophilic Substitution Approach, Compared with Carrier-Added <sup>18</sup>F-DOPA, Prepared by Conventional Electrophilic Substitution.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 1, p. 106, doi. 10.2967/jnumed.114.145730
- By:
- Publication type:
- Article
<sup>89</sup>Zr-Bevacizumab PET Visualizes Heterogeneous Tracer Accumulation in Tumor Lesions of Renal Cell Carcinoma Patients and Differential Effects of Antiangiogenic Treatment.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 1, p. 63, doi. 10.2967/jnumed.114.144840
- By:
- Publication type:
- Article
Everolimus Reduces <sup>89</sup>Zr-Bevacizumab Tumor Uptake in Patients with Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2014, v. 55, n. 7, p. 1087, doi. 10.2967/jnumed.113.129056
- By:
- Publication type:
- Article
<sup>89</sup>Zr-Bevacizumab PET Imaging in Primary Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 7, p. 1014, doi. 10.2967/jnumed.112.117218
- By:
- Publication type:
- Article
Clinical Relevance of <sup>18</sup>F-FDG PET and <sup>18</sup>F-DOPA PET in Recurrent Medullary Thyroid Carcinoma.
- Published in:
- Journal of Nuclear Medicine, 2012, v. 53, n. 12, p. 1863, doi. 10.2967/jnumed.112.105940
- By:
- Publication type:
- Article
Total Abdominal <sup>18</sup>F-FDG Uptake Reflects Intestinal Adenoma Burden in Apc Mutant Mice.
- Published in:
- Journal of Nuclear Medicine, 2011, v. 52, n. 3, p. 431, doi. 10.2967/jnumed.110.083956
- By:
- Publication type:
- Article
Head-to-head comparison of [<sup>11</sup>C]methionine PET, [<sup>11</sup>C]choline PET, and 4-dimensional CT as second-line scans for detection of parathyroid adenomas in primary hyperparathyroidism.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 4, p. 1050, doi. 10.1007/s00259-023-06488-7
- By:
- Publication type:
- Article
Towards in vivo characterization of thyroid nodules suspicious for malignancy using multispectral optoacoustic tomography.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 9, p. 2736, doi. 10.1007/s00259-023-06189-1
- By:
- Publication type:
- Article
Optimisation of scan duration and image quality in oncological <sup>89</sup>Zr immunoPET imaging using the Biograph Vision PET/CT.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 8, p. 2258, doi. 10.1007/s00259-023-06194-4
- By:
- Publication type:
- Article
EARL compliance and imaging optimisation on the Biograph Vision Quadra PET/CT using phantom and clinical data.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 13, p. 4652, doi. 10.1007/s00259-022-05919-1
- By:
- Publication type:
- Article
First-time imaging of [<sup>89</sup>Zr]trastuzumab in breast cancer using a long axial field-of-view PET/CT scanner.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3593, doi. 10.1007/s00259-022-05777-x
- By:
- Publication type:
- Article
[<sup>18</sup>F]FDG-PET/CT to prevent futile surgery in indeterminate thyroid nodules: a blinded, randomised controlled multicentre trial.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 6, p. 1970, doi. 10.1007/s00259-021-05627-2
- By:
- Publication type:
- Article
Clinically feasible semi-automatic workflows for measuring metabolically active tumour volume in metastatic melanoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 5, p. 1498, doi. 10.1007/s00259-020-05068-3
- By:
- Publication type:
- Article
Interobserver reproducibility of tumor uptake quantification with <sup>89</sup>Zr-immuno-PET: a multicenter analysis.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 9, p. 1840, doi. 10.1007/s00259-019-04377-6
- By:
- Publication type:
- Article
Lesion detection by [<sup>89</sup>Zr]Zr-DFO-girentuximab and [<sup>18</sup>F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 9, p. 1931, doi. 10.1007/s00259-019-04358-9
- By:
- Publication type:
- Article
Total F-dopa PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumour.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2011, v. 38, n. 10, p. 1854, doi. 10.1007/s00259-011-1862-5
- By:
- Publication type:
- Article
The effects of molar activity on [<sup>18</sup>F]FDOPA uptake in patients with neuroendocrine tumors.
- Published in:
- EJNMMI Research, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13550-021-00829-z
- By:
- Publication type:
- Article